GGrantIndex
Sort

166,118 grants matching stem cells

Accelerating vision restoration with in-vivo cellular imaging of retinal function

$831,713
David R Williams · University Of Rochester · U01 · FY2015 · EY

LTBR CARs as next-generation therapies for R/R lymphoma

$831,692
Neville Sanjana · New York Genome Center · R01 · FY2023 · CA

Improving STEM Retention through Instruction: Leveraging Faculty Expertise

$831,683
David F Feldon · University South Carolina Research Foundation · · FY2007 · EDU

Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies

$831,661
David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

iPSC-derived neurovascular tissue model of cerebral amyloiad angiopathy

$831,660
Ethan Lippmann · Vanderbilt University · R61 · FY2020 · NS

Engineering synthetic immune cells with modular sentinel and therapeutic functions for T1D

$831,627
Wendell A Lim · University Of California, San Francisco · R01 · FY2023 · DK

Stochastic gene expression in differentiation and development

$831,600
Alexander Van Oudenaarden · Massachusetts Institute Of Technology · DP1 · FY2011 · OD

Developing novel methods to measure DNA repair capacity in human populations

$831,600
Leona D Samson · Massachusetts Institute Of Technology · DP1 · FY2012 · ES

Stochastic gene expression in differentiation and development

$831,600
Alexander Van Oudenaarden · Massachusetts Institute Of Technology · DP1 · FY2012 · CA

Developing novel methods to measure DNA repair capacity in human populations

$831,600
Leona D Samson · Massachusetts Institute Of Technology · DP1 · FY2011 · OD

A novel product for tendinopathy treatment

$831,571
Li Sun · New York/R&D/Ctr/Translational Med/Ther · R44 · FY2021 · AG

TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimer’s Disease

$831,528
Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · AG

Mechanism of repeat expansion and chromosome fragility in Fragile X syndrome

$831,507
Karen P. Usdin · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK

Synthetic PreImplantation Factor (sPIF) plus hypothermia to treat neonatal brain injury

$831,440
Eytan R Barnea · Bioincept, Llc · R44 · FY2024 · HD

Mechanisms of actions(s) of simvastatin in uterine leiomyoma

$831,387
Mostafa A. Borahay · Johns Hopkins University · R01 · FY2018 · HD

Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD

$831,382
Rita Sattler · St. Joseph'S Hospital And Medical Center · R01 · FY2022 · NS

A Clinical Indications Prediction (CLIP) Scale for Human Mesenchymal Stem Cells

$831,359
Donald G Phinney · University Of Florida · R01 · FY2025 · HL

Balancing epithelial cell resistance and resilience to respiratory viral infections

$831,352
Jose Manuel Ordovas-Montanes · Boston Children'S Hospital · R01 · FY2025 · HL

Role of a novel risk loci HAVCR2 of late-onset Alzheimer's disease in the regulation of microglial response in neurodegeneration

$831,274
Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2023 · AG

Regulation of Fetal Hemoglobin Production in Humans.

$831,273
Jeffery Miller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK

Research Studies of Erythropoiesis and Iron Biology.

$831,273
Jeffery Miller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK

Regeneration of Retinal Neurons by Chemically Induced Reprogramming of Muller Gli

$831,267
Kang Zhang · University Of California, San Diego · R01 · FY2012 · EY

Regeneration of Retinal Neurons by Chemically Induced Reprogramming of Muller Gli

$831,267
Kang Zhang · University Of California, San Diego · R01 · FY2014 · EY

Predicting the multi-omic impact of psychiatric GWAS associations

$831,256
Laura Marianne Huckins · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · MH

Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins

$831,256
Vikram Khurana · Brigham And Women'S Hospital · R01 · FY2025 · NS